Friday, November 2, 2018

Emergent BioSolutions defends opioid overdose drug against generic competitor

The Gaithersburg biotech filed a lawsuit against a generic drugmaker for patent infringement, after it applied to market a generic version of Narcan Nasal Spray, which reverses the effects of opioid overdose.



from https://www.bizjournals.com/baltimore/news/2018/11/02/emergent-biosolutions-defends-opioid-overdose-drug.html?ana=RSS&s=article_search
via http://baltimorecheckbook.tumblr.com/post/179688496637

No comments:

Post a Comment